K147N Hemagglutinin Mutation Reduces C12H5 Neutralization in A(H1N1)pdm09

A study of A(H1N1)pdm09 hemagglutinin (HA) reports that the K147N hemagglutinin substitution reduced neutralization by the monoclonal antibody C12H5 (which the authors describe as cross-neutralizing across multiple H1N1 and H5N1 strains) and was also reported to be common in recent surveillance sequences.

The authors describe a workflow that coupled computational prioritization with reverse-genetics construction of single-point mutants, followed by functional neutralization assays and sequence-based epidemiology. Across mutation selection, laboratory readouts, and population sequence trends, the paper presents K147N as the key mutation identified in both the experimental and surveillance analyses.

Investigators report building an ESM-2–based antigen–antibody model to screen for candidate HA substitutions with potential to reduce C12H5 binding, using SHAP analysis to rank sites for follow-up testing. In their prioritization results, K147 was described as the top-ranked escape candidate, with a composite score of 0.92 and SHAP importance of 0.28. The study then moved from in silico ranking to wet-lab validation by generating recombinant viruses carrying candidate single substitutions via reverse genetics, enabling direct comparisons between a wild-type background and targeted mutants. The authors frame the next step as assessing whether prioritized substitutions translate into measurable escape in functional assays.

In functional testing, the authors report that K147N was the main substitution associated with reduced C12H5 activity across two assay formats. In hemagglutination inhibition testing, they describe an 8-fold reduction in HI titer for the K147N-bearing recombinant virus compared with wild type (1:1024 to 1:128). In a separate microneutralization assay in MDCK cells, they report an approximately 6-fold reduction in neutralization titer for the same substitution (8.3 log2 to 5.7 log2). The paper presents these as distinct readouts—receptor-binding inhibition versus neutralization of infectious virus—that converged on K147N as the leading escape signal. Overall, the reported assays indicate reduced C12H5 neutralizing performance against the K147N recombinant virus under the conditions tested.

To relate the mutation to HA topology, the study reports structural mapping that places residue 147 at the edge of the HA 130-loop (Pa antigenic site), adjacent to the receptor-binding domain and oriented toward the antibody-binding interface. The authors describe visualizing candidate sites on a referenced HA structure using their stated workflow, focusing on how prioritized residues spatially align with regions implicated in antibody recognition. In this depiction, K147 is presented as positioned near the receptor-binding site rather than buried in the HA core. The authors use this reported localization to support the plausibility that changes at 147 could affect antibody engagement.

Beyond neutralization, the authors report one-step growth-curve observations in MDCK cells sampled at 12, 24, 48, and 72 hours, in which titers for K147N were described as comparable to wild type early and higher during the mid-to-late phase (24–72 hours). They also describe sequence epidemiology from GISAID-derived HA data showing rapid expansion of K147N frequency, reaching 98.9% by 2023 and 99.6% by 2024, alongside broad geographic penetration across major regions in their analysis. In co-occurrence analyses, S164T and A203T were reported as enriched among sequences carrying K147N.

In the discussion, the authors characterize K147N as a critical escape mutation and suggest it could be relevant to broad-spectrum antibody optimization and considerations around influenza vaccine updates, based on their combined experimental and sequence analyses.

Key Takeaways:

• The authors report a workflow that prioritized HA sites computationally and then tested targeted single substitutions in recombinant viruses, with K147N emerging as the central candidate across steps.
• Across two functional neutralization readouts, investigators observed reduced C12H5 activity against the K147N-bearing recombinant virus, with both assays pointing to the same substitution as the primary escape signal.
• The study reports K147’s placement near the 130-loop/receptor-binding interface, a mid-to-late replication kinetics pattern in MDCK cells, and rapid surveillance emergence with enrichment of co-occurring substitutions (including S164T and A203T).